Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.27 USD | +0.79% | -5.22% | +8.55% |
Apr. 16 | Clearside Biomedical, Inc Appoints Anthony S. Gibney to its Board of Directors | CI |
Mar. 18 | Clearside Biomedical Names Victor Chong Chief Medical Officer | MT |
Financials (USD)
Sales 2024 * | 2.74M | Sales 2025 * | 7.36M | Capitalization | 94.91M |
---|---|---|---|---|---|
Net income 2024 * | -39M | Net income 2025 * | -43M | EV / Sales 2024 * | 26.9 x |
Net cash position 2024 * | 21.26M | Net Debt 2025 * | 12.33M | EV / Sales 2025 * | 14.6 x |
P/E ratio 2024 * |
-2.41
x | P/E ratio 2025 * |
-2.19
x | Employees | 30 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.7% |
Latest transcript on Clearside Biomedical, Inc.
1 day | +0.79% | ||
1 week | -5.22% | ||
Current month | +0.79% | ||
1 month | -19.62% | ||
3 months | -4.51% | ||
6 months | +66.45% | ||
Current year | +8.55% |
Managers | Title | Age | Since |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 17-08-07 |
Charles Deignan
DFI | Director of Finance/CFO | 59 | 11-12-31 |
Susan L. Coultas
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 17-08-07 |
Jeffrey Edwards
BRD | Director/Board Member | 64 | 18-09-25 |
Christy Shaffer
BRD | Director/Board Member | 66 | 11-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 1.27 | +0.79% | 92,542 |
24-04-30 | 1.26 | -2.33% | 111,829 |
24-04-29 | 1.29 | -3.73% | 110,774 |
24-04-26 | 1.34 | +6.35% | 154,219 |
24-04-25 | 1.26 | -5.97% | 135,399 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.55% | 94.16M | |
-1.17% | 102B | |
+2.87% | 96.09B | |
+2.13% | 22.28B | |
-14.77% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.21% | 16.09B | |
+8.55% | 13.83B | |
+35.75% | 11.97B |
- Stock Market
- Equities
- CLSD Stock